|4Mar 31, 4:11 PM ET

Krandel Judy 4

4 · NEPHROS INC · Filed Mar 31, 2025

Insider Transaction Report

Form 4
Period: 2025-03-27
Krandel Judy
Chief Financial Officer
Transactions
  • Award

    Stock Option (right to buy)

    2025-03-27+54,35954,359 total
    Exercise: $1.68Exp: 2035-03-27Common Stock (54,359 underlying)
Holdings
  • Stock Option (right to buy)

    Exercise: $1.71Exp: 2033-11-01Common Stock (122,524 underlying)
    122,524
Footnotes (2)
  • [F1]Options to purchase 30,631 shares vest on 11/1/24 and options to purchase the remaining 91,893 shares vest quarterly in 12 equal amounts commencing on 2/1/2025.
  • [F2]Options to purchase 13,589 shares vest on 3/27/2026 and options to purchase the remaining 40,770 shares vest quarterly in 12 equal amounts commencing on 6/27/2026.

Documents

2 files
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

  • EX-24